RhoVac’s rights issue heavily oversubscribed – subscribed to 196 percent
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL.On 1 June 2018, the subscription period ended in the rights issue in RhoVac AB (publ) (“RhoVac” or “the Company”), which was made public on the 9 April 2018. The result shows that 1,159,045 shares, corresponding to 85.2 percent of the offered shares where subscribed for with subscription rights. In addition, subscriptions corresponding to 1,513,788 shares have been received without subscription rights.